US stocks ended another week in the red as the war raging through the Gulf region rolls on with no end in sight and US equity ...

Hello, and welcome to Wave Life Sciences Positive Interim Phase I Clinical Data from INLIGHT Trial of WVE-007 for Obesity Call. [Operator Instructions] Also, as a reminder, this conference is being ...

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a ...

A reporting team used stats, R coding, and new datasets to investigate why U.S. overdose deaths declined unevenly, showing ...

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on ...

Franklin Templeton CEO Jenny Johnson leads a global fund manager with nearly $2 billion in assets and a 79-year-old family ...

Detailed price information for Profound Medical Corp (PRN-T) from The Globe and Mail including charting and trades.

Existing loss of well control event indicators fall short of predicting events in an accurate and timely manner due to a lack ...

The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.